Literature DB >> 11750218

A clinical study on the association of Trichomonas vaginalis and Mycoplasma hominis infections in women attending a sexually transmitted disease (STD) outpatient clinic.

A van Belkum1, C van der Schee, W I van der Meijden, H A Verbrugh, H J Sluiters.   

Abstract

Swabs from the posterior vaginal fornix were obtained from 804 consecutive female patients visiting a large Dutch sexually transmitted diseases (STD) outpatient clinic. A detailed clinical history was obtained and complaints concerning the lower genital tract, such as vaginal discharge or vulval and vaginal irritation, were recorded. Patients were examined and the presence of non-physiological vaginal secretions was established by speculum examination. The swabs were monitored for bacterial vaginosis (BV) or Candida albicans infection. PCR diagnosis of Chlamydia trachomatis and Trichomonas vaginalis was performed as well. Four groups of patients (n=14-21) with BV or single infections caused by one of these three pathogens and a control group with no pathogens were selected and Mycoplasma hominis PCR was performed additionally. At clinical presentation, controls and single-infected patient groups were comparable with regard to complaints of the lower genital tract and sexual risk behavior defined as having prior STDs and/or admitted prostitution. Only in the T. vaginalis-positive group significantly more women reporting sexual risk behavior were found than in controls. In agreement with former in vitro observations, an in vivo association between the PCR-detected presence of M. hominis and T. vaginalis was established. In 79% of all samples positive for T. vaginalis, M. hominis could be detected, as compared to only 6% in control samples (P=0.0004). However, since single infections by either of the two pathogens were regularly observed, there does not seem to be an exclusive association between the species, as the bacterium is also more frequently found in cases of BV (P=0.026). Co-infection of M. hominis with C. albicans (11%) or C. trachomatis (0%) did not differ significantly from controls (6%). M. hominis did not associate with complaints of the lower genital tract. However, if all groups were combined there appears to be a very significant association between the presence of M. hominis and sexual risk behavior (P=0.0004). M. hominis and sexual risk behavior were more closely associated than M. hominis and T. vaginalis. No indications were found for an enhanced pathogenicity by either of the symbionts.

Entities:  

Mesh:

Year:  2001        PMID: 11750218     DOI: 10.1111/j.1574-695X.2001.tb00529.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  9 in total

1.  Bacterial vaginosis: culture- and PCR-based characterizations of a complex polymicrobial disease's pathobiology.

Authors:  Apoorv Kalra; Cristina T Palcu; Jack D Sobel; R A Akins
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

2.  Study of the prevalence and association of ocular chlamydial conjunctivitis in women with genital infection by Chlamydia trachomatis, Mycoplasma genitalium and Candida albicans attending outpatient clinic.

Authors:  Rania Abdelmonem Khattab; Maha Mohssen Abdelfattah
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

3.  Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma.

Authors:  Raina Fichorova; Jorge Fraga; Paola Rappelli; Pier Luigi Fiori
Journal:  Res Microbiol       Date:  2017-03-31       Impact factor: 3.992

4.  Long-term survival and intracellular replication of Mycoplasma hominis in Trichomonas vaginalis cells: potential role of the protozoon in transmitting bacterial infection.

Authors:  Daniele Dessì; Giuseppe Delogu; Eleonora Emonte; Maria Rosaria Catania; Pier Luigi Fiori; Paola Rappelli
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis.

Authors:  Keonte J Graves; Jan Novak; W Evan Secor; Patricia J Kissinger; Jane R Schwebke; Christina A Muzny
Journal:  Parasitology       Date:  2020-07-30       Impact factor: 3.234

6.  Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.

Authors:  Sara E Butler; Peter Augostini; W Evan Secor
Journal:  Parasitol Res       Date:  2010-07-21       Impact factor: 2.289

7.  Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection.

Authors:  David H Martin; Marcela Zozaya; Rebecca A Lillis; Leann Myers; M Jacques Nsuami; Michael J Ferris
Journal:  J Infect Dis       Date:  2013-03-12       Impact factor: 5.226

8.  The presence of Mycoplasma hominis in isolates of Trichomonas vaginalis impacts significantly on DNA fingerprinting results.

Authors:  J C Xiao; L F Xie; L Zhao; S L Fang; Z R Lun
Journal:  Parasitol Res       Date:  2007-12-06       Impact factor: 2.289

9.  Urogenital pathogens, associated with Trichomonas vaginalis, among pregnant women in Kilifi, Kenya: a nested case-control study.

Authors:  Simon C Masha; Piet Cools; Patrick Descheemaeker; Marijke Reynders; Eduard J Sanders; Mario Vaneechoutte
Journal:  BMC Infect Dis       Date:  2018-11-06       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.